Active Ingredient: RIZATRIPTAN BENZOATE
Proprietary Name: RIZATRIPTAN BENZOATE
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A203146
Product Number: 002
Approval Date: Sep 19, 2014
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information